Sacituzumab govitecan plus platinum-based chemotherapy effective in multiple carcinomas

FHS
March 5, 2024
3:46 pm

A new research paper was published in Oncotarget’s Volume 15 on February 22, 2024, entitled, “Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.”

Almirall, Absci partner on dermatological drug development

Share this article The companies will develop treatment candidates for two targets in dermatology. Credit: Chokniti-Studio / Shutterstock.com. Almirall has entered an artificial intelligence (AI)-driven drug

November 15, 2023

Viromed Medical AG seeks extensive cooperation with a major global Group – Biotech Investments

Viromed Medical AG / Key word(s): Alliance Viromed Medical AG seeks extensive cooperation with a major global Group 11-Dec-2024 / 21:45 CET/CEST Disclosure of an

December 12, 2024

How Can the U.S. Prevent Future Cyberattacks Like the One on Change Healthcare?

The federal government could be doing more to prevent cyberattacks like the one that happened to Change Healthcare, the UnitedHealth Group (UHG) subsidiary, a cybersecurity

March 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.